{"id":"W1979497236","doi":"10.1038/leu.2011.329","title":"Oral high-dose glucocorticoids and Ofatumumab in fludarabine-resistant Chronic Lymphocytic Leukemia","year":2011,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Health Canada; GlaxoSmithKline","keywords":"Ofatumumab; Fludarabine; Chronic lymphocytic leukemia; Medicine; Leukemia; Vidarabine; Internal medicine; Oncology; Cancer research; Immunology; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001081336,0.0006269514,0.001100216,0.0006249901,0.001746684,0.001217146,0.0007050171,0.01019009,0.001790705],"category_scores_gemma":[0.005144221,0.0003272453,0.0008926003,0.0005502567,0.001119683,0.001477406,0.0004264387,0.006125507,0.000805007],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002725637,"about_ca_system_score_gemma":0.001226061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002314531,"about_ca_topic_score_gemma":0.006368423,"domain_scores_codex":[0.9993367,0.0002800579,0.00008664064,0.00005037537,0.0001251746,0.000121127],"domain_scores_gemma":[0.9982809,0.001128532,0.0001352174,0.00005667813,0.00009776081,0.0003010251],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.003772658,0.0007691658,0.03218016,0.0006103909,0.0002732582,0.5166618,0.0005746738,0.001064275,0.003458067,0.007504565,0.3332801,0.09985095],"study_design_scores_gemma":[0.00440974,0.002860591,0.03597745,0.001083182,0.000586375,0.5569962,0.001611713,0.00518245,0.002229586,0.0145374,0.374385,0.0001403157],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1183333,0.03593874,0.001078613,0.7765657,0.02528455,0.000169553,0.0002118883,0.0001225317,0.04229518],"genre_scores_gemma":[0.5390475,0.02390737,0.001992658,0.3341752,0.08184829,0.000152579,0.000229989,0.00005213144,0.01859426],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01019009,"threshold_uncertainty_score":0.01977593,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02322131647054599,"score_gpt":0.2723016917277518,"score_spread":0.2490803752572058,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}